Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

n/a
Abstract Title:

changes lipidemic profile and gut microbiota in a hamster hypercholesterolemic model.

Abstract Source:

Benef Microbes. 2019 May 28 ;10(5):555-567. Epub 2019 May 15. PMID: 31090460

Abstract Author(s):

F Briand, T Sulpice, P Giammarinaro, X Roux

Article Affiliation:

F Briand

Abstract:

Hypercholesterolemia is a main risk factor of cardiovascular disease. Probiotics are a safe approach to reduce elevated cholesterol without any deleterious effect to human health.CNCM I-745 probiotic properties are well documented in a context of intestinal dysbiosis. Recentand preclinical studies have suggested its potential effects on dyslipidemia. This is the first controlled study investigating the effects ofCNCM I-745 on lipidemic profile and gut microbiota in a hamster hypercholesterolemic model. Daily administration (3 g/kg) offor 21 or 39 days in hamsters fed a 0.3% cholesterol-diet significantly reduced total plasma cholesterol (<0.001) and increased faecal total cholesterol (<0.05) compared to vehicle-treated animals.significantly modified the gut microbiota composition of the hamster fed a 0.3% cholesterol-diet. These microbial abundancy modifications of the microbiota were correlated to variations of lipidemic values or liver genes expressions. In particularly we found that abundance of g_, the most modified taxon aftertreatment (+236%;<0.05), was correlated to variations in plasmatic lipoproteins level andhepatic gene expression. We also observed a not previously described correlation between the levels of g_in the gut microbiota and total cholesterol plasma concentration. In conclusion, we confirmed the cholesterol-lowering effects ofintake and we demonstrated for the first time theeffect on gut microbiota in the context of hypercholesterolemia in hamsters. Our results provide new insights for a beneficial and safe approach of hypercholesterolemia treatment and could be considered for clinical development, alone or in addition to conventional treatment.

Study Type : Animal Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.